I'm happy to share our latest work published in @PLOSBiology. Here we describe a zebrafish model of SLC13A5 epilepsy and show how modulating zinc chelation and NMDA signaling can prevent seizure-like events. 1/2
https://t.co/wkdcwpJz99
Excited to share our latest article. 7 years ago my then 9 year old son was diagnosed with K210del DCM. With the help of my colleagues @Joseph_C_Wu, @sadayappanlab and Enzo Porrello we identified an FDA approved drug that corrects the mutation.
JCI - An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models https://t.co/abhRTjcXY3
🚨 Job Alert! Please RT 🙏
Fully-funded postdoc positions (4+2 years) available! Join the dynamic, collaborative community @TheCrick with access to top-tier technology platforms and an outstanding postdoc training program.
https://t.co/03Y79cXm0P
Within one day of eating a large meal, a python’s heart grows nearly 25% larger. Unraveling this rapid postprandial cardiac growth could aid the development of therapies for cardiovascular diseases. In PNAS: https://t.co/CmMqKm8bsF
Brain #pericytes are critical regulators of endothelial barrier function. @Ahuja_Suchit @SarahChildsYYC &co show that the TF nkx3.1 is critical for generating an intermediate precursor cell state necessary for normal development of pericytes #PLOSBiology https://t.co/ooU5WueK8M
📢 Calling postdocs past and present!
#eLifeAmbassador @HaageVc is looking to hear from you about your experiences as a postdoc to shed light on why so many leave their positions prematurely. Find the multi-language survey here: https://t.co/g3IRWWlYJh
Today we approved two milestone treatments - the first cell-based gene therapies to treat sickle cell disease in patients 12 years and older. https://t.co/az8lDdRyz0
No vein no gain: a venous origin for blood vessel defects
Read this Research Highlight showcasing work from Jasper Greysson-Wong @jgreyssonwong, Sarah Childs @SarahChildsYYC and colleagues:
https://t.co/1fffkaWVEi
We’re excited to announce that recruitment is open for our first-in-human clinical trial!
If you have quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS), you may qualify. Learn more about our trial by visiting our recent blog post.
https://t.co/mPLKFelOnD
Our lab is hiring postdocs for 3 funded projects on hypothalamic development and function using brain organoids and mice with advanced microscopy, single cell ‘omics, in utero electroporation. If interested, pls email your CV+cover letter to Dr. Kurrasch ([email protected]).
A huge thanks to T. Boone Pickens Foundation for supporting the research at the Hotchkiss Brain Institute!! Delighted to have our brain organoid work featured today! @HotchkissBrain@UCalgary@KurraschLab Don't miss the video!😉🧠
https://t.co/QMwPBQ7cIg
Happy to share our work on zebrafish kcna1a mutant modeling episodic ataxia and epilepsy, that is now published in Epilepsia @EpilepsiaJourn
. Congratulations to all the co-authors!! @KurraschLab
https://t.co/dnLMuPlNdt